Loading people...
Brenton Fargnoli is a Partner at AlleyCorp, a prominent venture capital firm and incubator. He is known for his expertise in early-stage investments, particularly within the healthcare, enterprise software, and fintech sectors.
Brenton Fargnoli primarily invests in early-stage companies across three key sectors: healthcare (including digital health and health tech), enterprise software (SaaS and B2B solutions), and fintech. He seeks innovative startups with strong potential for disruption and growth.
Brenton Fargnoli works as a Partner at AlleyCorp. AlleyCorp is a New York City-based venture capital firm and incubator known for building and investing in successful technology companies.
Brenton Fargnoli is a Partner at Lightspeed Venture Partners in New York City, where he co-leads healthcare and artificial intelligence investments. Before joining Lightspeed in 2025, he served as Managing Partner at AlleyCorp, establishing its healthcare practice in 2019 and building it into the most active early-stage healthtech investor in the US. His operational background includes serving as an executive at Flatiron Health through its $1.9 billion acquisition by Roche, and helping launch OneOncology, which was later acquired for approximately $2 billion. As an investor and board member, he has backed multiple digital health startups, including Pearl Health, which raised a $75 million Series B in 2023, alongside Thyme Care and Clarium Health. A board-certified physician with an MD and MBA from the University of Pennsylvania, Fargnoli combines clinical and financial expertise to scale medical technology companies.
Brenton Fargnoli stands as a pivotal figure at AlleyCorp, a renowned New York City-based venture capital firm and incubator. As a Partner, he plays a crucial role in identifying, funding, and nurturing the next generation of groundbreaking companies. His work at AlleyCorp involves not only capital deployment but also active engagement in company building, leveraging the firm's unique model that combines venture investing with hands-on operational support.
Fargnoli's investment philosophy is deeply rooted in early-stage opportunities, focusing primarily on seed and Series A rounds. He is particularly known for his expertise and keen eye in three high-growth sectors: healthcare, enterprise software, and fintech. Within healthcare, his interests span digital health, health tech innovations, and solutions that aim to improve patient outcomes and healthcare efficiency. In enterprise software, he seeks out B2B SaaS platforms and other solutions that drive productivity, automation, and digital transformation for businesses of all sizes. His fintech investments target disruptive technologies that are reshaping financial services, from payments and lending to wealth management and blockchain applications.
Before his tenure as a Partner at AlleyCorp, Brenton Fargnoli cultivated a robust career in venture capital and growth equity. This background provided him with a comprehensive understanding of market dynamics, investment strategies, and the operational challenges faced by scaling startups. His prior experiences have equipped him with a valuable perspective on how to best support founders, offering strategic guidance beyond just financial capital. He is known for his collaborative approach, working closely with entrepreneurs to navigate product development, market entry, and team building.
At AlleyCorp, Fargnoli contributes significantly to the firm's impressive portfolio, which includes numerous successful ventures across various industries. While specific individual investments are often part of a broader firm effort, his influence is evident in the strategic direction and growth of companies within his focus areas. He is committed to backing visionary founders who are tackling complex problems with innovative solutions, aiming to create lasting impact and generate substantial returns.
Brenton Fargnoli's dedication to fostering innovation and his strategic insights make him a key player in the venture capital landscape. His work at AlleyCorp continues to shape the future of technology and healthcare, solidifying his reputation as a discerning investor with a profound commitment to entrepreneurial success.
